CSL Ltd
ASX:CSL
CSL Ltd
Total Current Liabilities
CSL Ltd
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CSL Ltd
ASX:CSL
|
Total Current Liabilities
$4.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
20%
|
|
Immutep Ltd
ASX:IMM
|
Total Current Liabilities
AU$6.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
Mesoblast Ltd
ASX:MSB
|
Total Current Liabilities
$31.4m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Total Current Liabilities
AU$29.4m
|
CAGR 3-Years
51%
|
CAGR 5-Years
63%
|
CAGR 10-Years
32%
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Total Current Liabilities
AU$157.4m
|
CAGR 3-Years
99%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Total Current Liabilities
AU$8.6m
|
CAGR 3-Years
95%
|
CAGR 5-Years
39%
|
CAGR 10-Years
26%
|
See Also
What is CSL Ltd's Total Current Liabilities?
Total Current Liabilities
4.7B
USD
Based on the financial report for Dec 31, 2023, CSL Ltd's Total Current Liabilities amounts to 4.7B USD.
What is CSL Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
20%
Over the last year, the Total Current Liabilities growth was 9%. The average annual Total Current Liabilities growth rates for CSL Ltd have been 21% over the past three years , 20% over the past five years , and 20% over the past ten years .